<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33648">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02147119</url>
  </required_header>
  <id_info>
    <org_study_id>PG13/32/30205</org_study_id>
    <nct_id>NCT02147119</nct_id>
  </id_info>
  <brief_title>Radial Artery Function Following Trans-radial Cardiac Catheterisation</brief_title>
  <official_title>Radial Artery Function Following Trans-radial Cardiac Catheterisation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Edinburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>British Heart Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Edinburgh</source>
  <oversight_info>
    <authority>United Kingdom: Research Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will study Radial artery injury and endothelial function following
      trans-radial cardiac catheterisation. Radial artery injury will be quantified pre- and post-
      angiography using Optical Coherence Tomography. The participants will also have radial
      endothelial function assessed using flow-mediated dilatation at baseline, 24 hours, one
      week, one month and three months post- angiography. Blood will be taken pre and 24 hours
      post angiography for characterisation of endothelial progenitor cell numbers and function.
      The hypothesis is that trans-radial catheterisation will cause a reduction in flow-mediated
      dilatation which peaks at 24 hours and recovers at three months. The investigators hope to
      correlate the rate of this recovery with peri-procedural progenitor cell numbers.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">January 2015</completion_date>
  <primary_completion_date type="Anticipated">January 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Change in Flow-mediated dilatation</measure>
    <time_frame>baseline, 24 hours, one week, four weeks and three months post-angiography</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radial artery flow-mediated dilatation will be assessed at the above stated time points</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radial artery injury</measure>
    <time_frame>Baseline and up to 1 hour Post angiograpy sheath insertion</time_frame>
    <safety_issue>No</safety_issue>
    <description>Optical coherence tomography examination of the radial artery will be made at baseline and following sheath insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial progenitor cell number an function Endothelial progenitor cell number and function</measure>
    <time_frame>Baseline and at 24 hours post-angiogram</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">51</enrollment>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Patients post- cardiac catheterisation</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angiography</intervention_name>
    <arm_group_label>Patients post- cardiac catheterisation</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Stable outpatient population attending for angiography
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Stable outpatient population aged between 18-85 attending for trans-radial cardiac
             catheterisation

        Exclusion Criteria:

          -  Recent myocardial infarction (&lt;3 months)

          -  Severe aortic stenosis

          -  Chronic renal failure (eGFR&lt;30)

          -  Inability to give informed consent
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew J Mitchell, MBChB</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Edinburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew J Mitchell, MBChB</last_name>
    <phone>00447725579609</phone>
    <email>andrewjmitchell@doctors.org.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical research facility University Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <state>Midlothian</state>
        <zip>eh164sa</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew J Mitchell, MBChB</last_name>
      <phone>00447725579609</phone>
      <email>andrewjmitchell@doctors.org.uk</email>
    </contact>
    <investigator>
      <last_name>Andrew J Mitchell, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Nick LM Cruden, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dave E Newby, MBChB</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>May 23, 2014</lastchanged_date>
  <firstreceived_date>April 7, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Atherosclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
